Pasar al contenido principal

ESTUDIO DE LOS MECANISMOS QUE REGULAN LA ACTIVIDAD CITOPLASMATICA DEL COMPLEJO CYCD1-CDK4. CARACTERIZACION DE SU RELEVANCIA FUNCIONAL EN MAMIFEROS

BFU2013-42895-P

•
Nombre agencia financiadora Ministerio de Economía y Competitividad
Acrónimo agencia financiadora MINECO
Programa Programa Estatal de Fomento de la Investigación Científica y Técnica de Excelencia
Subprograma Subprograma Estatal de Generación de Conocimiento
Convocatoria Proyectos de I+D (Excelencia / Generación de Conocimiento)
Año convocatoria 2013
Plan Estatal 2013-2016 Plan Estatal de Investigación Científica y Técnica y de Innovación
Unidad de gestión Secretaría de Estado de Educación, Formación Profesional y Universidades
Centro beneficiario UNIVERSIDAD DE LLEIDA
Identificador persistente http://dx.doi.org/10.13039/501100003329

Resultados relacionados

Resultados totales (Incluyendo duplicados): 15
Encontrada(s) 1 página(s)

Repositori Obert UdL
Publicación Artículo científico (JournalArticle)

Cyclin D1 promotes tumor cell invasion and metastasis by cytoplasmic mechanisms

  • Pérez Fusté, Noel
  • Ferrezuelo, Francisco
  • Garí Marsol, Eloi
Amplification of cyclin D1 is a frequent alteration in many cancers of different type and origin. We recently described a novel regulatory axis involving cyclin D1 in the regulation of tumor invasion and metastasis. Membrane-associated cyclin D1-CDK4 complexes promote activation of the small GTPase RAC1 through phosphorylation of the regulatory protein paxillin., This work has been supported by research grants from Spanish Ministry of Education and Science (BFU2013-42895), Catalan Government (SGR-559), and Fundació Alicia Cuello de Merigó.
Repositori Obert UdL
Publicación Artículo científico (JournalArticle)

Polyphosphate is a key factor for cell survival after DNA damage in eukaryotic cells

  • Bru, Samuel
  • Samper Martín, Bàrbara
  • Quandt, Eva
  • Hernández Ortega, Sara
  • Martínez Laínez, Joan M
  • Garí Marsol, Eloi
  • Rafel i Borrell, Marta
  • Torres Torronteras, Javier
  • Martí, Ramón
  • Ribeiro, Mariana
  • Jiménez, Javier
  • Clotet, Josep
Cells require extra amounts of dNTPs to repair DNA after damage. Polyphosphate (polyP) is an evolutionary conserved linear polymer of up to several hundred inorganic phosphate (Pi) residues that is involved in many functions, including Pi storage. In the present article, we report on findings demonstrating that polyP functions as a source of Pi when required to sustain the dNTP increment essential for DNA repair after damage. We show that mutant yeast cells without polyP produce less dNTPs upon DNA damage and that their survival is compromised. In contrast, when polyP levels are ectopically increased, yeast cells become more resistant to DNA damage. More importantly, we show that when polyP is reduced in HEK293 mammalian cell line cells and in human dermal primary fibroblasts (HDFa), these cells become more sensitive to DNA damage, suggesting that the protective role of polyP against DNA damage is evolutionary conserved. In conclusion, we present polyP as a molecule involved in resistance to DNA damage and suggest that polyP may be a putative target for new approaches in cancer treatment or prevention., We would like to thank all the members of our group (E. Bállega, O. Mirallas, M. Ribeiro, A. Sánchez, B. Semper, and R. Carballar) for day-to-day talks, and Marta Pérez for technical assistance. The yeast ppn1Δ, ppn2Δ, ppx1Δ strain is a kind gift from A Mayer (Université de Lausanne). This work was supported by funding from the Spanish Government, with a MINECO grant (Ref: BFU 2013-44189-P) awarded to J. Clotet and a MICINN grant (Ref: BFU 2013-42895-P) awarded to E. Garí. J.M.M. was the recipient of a post-graduate Junior Faculty Fellowship from the UIC and l’Obra Social la Caixa.
Repositori Obert UdL
Publicación Artículo científico (JournalArticle)

Characterization of cytoplasmic cyclin D1 as a marker of invasiveness in cancer

  • Pérez Fusté, Noel
  • Castelblanco Echavarría, Esmeralda
  • Felip Nogués, Isidre
  • Santacana Espasa, Maria
  • Fernández Hernández, Rita
  • Gatius Calderó, Sònia
  • Pedraza González, Neus
  • Pallares, Judit
  • Cemeli, Tània
  • Valls Marsal, Joan
  • Tarrés Escalona, Marc
  • Ferrezuelo, Francisco
  • Dolcet Roca, Xavier
  • Matias-Guiu, Xavier
  • Garí Marsol, Eloi
Cyclin D1 (Ccnd1) is a proto-oncogen amplified in many different cancers and nuclear accumulation of Ccnd1 is a characteristic of tumor cells. Ccnd1 activates the transcription of a large set of genes involved in cell cycle progress and proliferation. However, Ccnd1 also targets cytoplasmic proteins involved in the regulation of cell migration and invasion. In this work, we have analyzed by immunohistochemistry the localization of Ccnd1 in endometrial, breast, prostate and colon carcinomas with different types of invasion. The number of cells displaying membranous or cytoplasmic Ccnd1 was significantly higher in peripheral cells than in inner cells in both collective and pushing invasion patterns of endometrial carcinoma, and in collective invasion pattern of colon carcinoma. Also, the cytoplasmic localization of Ccnd1 was higher when tumors infiltrated as single cells, budding or small clusters of cells. To evaluate cytoplasmic function of cyclin D1, we have built a variant (Ccnd1-CAAX) that remains attached to the cell membrane therefore sequestering this cyclin in the cytoplasm. Tumor cells harboring Ccnd1-CAAX showed high levels of invasiveness and metastatic potential compared to those containing the wild type allele of Ccnd1. However, Ccnd1- CAAX expression did not alter proliferative rates of tumor cells. We hypothesize that the role of Ccnd1 in the cytoplasm is mainly associated with the invasive capability of tumor cells. Moreover, we propose that subcellular localization of Ccnd1 is an interesting guideline to measure cancer outcome., This work was funded by Spanish Ministry of Education and Science (BFU2010-20293/ BMC and BFU2013-42895-P), Catalan Government (SGR-559), and Fondo de Investigaciones Sanitarias (PI10/00604 and PI13/00263). X.M-G was supported by grants 2014SGR138, RD12/0036/0013, and Fundación Asociación Española contra el Cancer. Tumour samples were obtained with the support of Xarxa Catalana de Bancs de Tumors, and Plataforma de Biobancos ISCIII (PT13/0010/0014). NP. Fusté was supported by a contract from “Fundació Alicia Cuello de Merigó”. I. Felip and T. Cemeli were supported by a predoctoral fellowship from FPU-MINECO.
Repositori Obert UdL
Publicación Artículo científico (JournalArticle)

Palbociclib has antitumour effects on Pten-deficient endometrial neoplasias, Inhibition of Cyclin D-CDK4/6 axis in PTEN-deficient neoplasias

  • Dosil Garcia, Maria Alba
  • Mirantes Barbeito, Cristina
  • Eritja Sánchez, Núria
  • Felip Nogués, Isidre
  • Navaridas Fernández de Bobadilla, Raúl
  • Gatius Calderó, Sònia
  • Santacana Espasa, Maria
  • Colás, Eva
  • Moiola, Cristian P.
  • Schoenenberger, Joan Antoni
  • Encinas Martín, Mario
  • Garí Marsol, Eloi
  • Matias-Guiu, Xavier
  • Dolcet Roca, Xavier
PTEN is one of the most frequently mutated genes in human cancers. The frequency of PTEN alterations is particularly high in endometrial carcinomas. Loss of PTEN leads to dysregulation of cell division, and promotes the accumulation of cell cycle complexes such as cyclin D1-CDK4/6, which is an important feature of the tumour phenotype. Cell cycle proteins have been presented as key targets in the treatment of the pathogenesis of cancer, and several CDK inhibitors have been developed as a strategy to generate new anticancer drugs. Palbociclib (PD-332991) specifically inhibits CDK4/6, and it has been approved for use in metastatic breast cancer in combination with letrazole. Here, we used a tamoxifen-inducible Pten knockout mouse model to assess the antitumour effects of cyclin D1 knockout and CDK4/6 inhibition by palbociclib on endometrial tumours. Interestingly, both cyclin D1 deficiency and palbociclib treatment triggered shrinkage of endometrial neoplasias. In addition, palbociclib treatment significantly increased the survival of Pten-deficient mice, and, as expected, had a general effect in reducing tumour cell proliferation. To further analyse the effects of palbociclib on endometrial carcinoma, we established subcutaneous tumours with human endometrial cancer cell lines and primary endometrial cancer xenografts, which allowed us to provide more translational and predictive data. To date, this is the first preclinical study evaluating the response to CDK4/6 inhibition in endometrial malignancies driven by PTEN deficiency, and it reveals an important role of cyclin D-CDK4/6 activity in their development., This work was supported by grants FIS PI13/00263, SAF2016-80157-R, PI13/01701, 2009SGR794,Grupos estables AECC (AECC2011), RETICS(RD12/0036/0013), Catalunya contra el cáncer, Programa de intensificación de la investigación, Instituto Carlos III, and BFU 2013-42895-P. MAD holds a predoctoral fellowship from Ministerio de Educación
Repositori Obert UdL
Publicación Artículo científico (JournalArticle)

Cytoplasmic Cyclin D1 regulates glioblastoma dissemination, Ccnd1-dependent GBM spread

  • Cemeli, Tània
  • Guasch Vallés, Marta
  • Nàger Grifo, Mireia
  • Felip Nogués, Isidre
  • Cambray Carner, Serafí
  • Santacana Espasa, Maria
  • Gatius Calderó, Sònia
  • Pedraza González, Neus
  • Dolcet Roca, Xavier
  • Ferrezuelo, Francisco
  • Schuhmacher, Alberto J.
  • Herreros Danés, Judit
  • Garí Marsol, Eloi
Glioblastoma (GBM) is a highly invasive brain neoplasia with an elevated recurrence rate after surgical resection. The CyclinD1 (Ccnd1)/Cdk4-RB1 axis is frequently altered in GBM, leading to over-proliferation by RB1 deletion or by Ccnd1/Cdk4 over-activation. By not so well understood mechanisms, high levels of Ccnd1-Cdk4 also promote GBM cell invasion. The purpose of this work is to elucidate the in vivo role of cytoplasmic Ccnd1-Cdk4 activity in the dissemination of GBM. We show that Ccnd1 activates invasion of primary human GBM cells through cytoplasmic RB1-independent mechanisms. By using GBM mouse models, we observed that evaded GBM cells showed cytoplasmic Ccnd1 co-localizing with regulators of cell invasion such as RalA and Paxillin. Our genetic data strongly suggest that, in GBM cells, the Ccnd1/Cdk4 complex is acting upstream of those regulators. Accordingly, expression of Ccnd1 induces FAK, RalA and Rac1 activities. Finally, in vivo experiments demonstrated increased GBM dissemination after expression of membrane-targeted Ccnd1. We conclude that Ccnd1-Cdk4 activity promotes GBM dissemination through cytoplasmic and RB1-independent mechanisms. Therefore, inhibition of Ccnd1-Cdk4 activity may be useful to hinder dissemination of recurrent GBM., We thank Sonia Rius, Marta Rafel, Laura Colas, Ana Velasco and Maria Ruiz (IRBLleida-Biobank) for technical assistance, and Maria Jesus Artiga and Patricia Gonzalez from Biobank and Histopathology Core Unit, CNIO for technical support. We especially thank Massimo Squatrito for providing the samples of the gliomagenesis model. This work was funded by the Spanish Ministry of Education and Science (BFU2013-42895-P; BFU2016-78826-P) and the Instituto de Salud Carlos III/FEDER (P13/01980), and supported by the Xarxa de Bancs de Tumors de Catalunya sponsored by Pla Director d'Oncologia de Catalunya (XBTC), IRBLleida Biobank (B.0000682) and PLATAFORMA BIOBANCOS PT17/0015/0027. T Cemeli (FPU13/06590) and I Felip (FPU14/02674) were supported by a predoctoral fellowship from Ministerio de Educacion, Cultura y Deportes and from Diputacio de Lleida. M Guasch and M Nager were supported by a predoctoral fellowship from UdL. AJ Schuhmacher was supported by a research contract from the Ramon y Cajal program (RYC-2015-17622) by the Spanish Ministry for the Economy, Industry and Competitiveness (MINECO).
Repositori Obert UdL
Publicación Artículo científico (JournalArticle)

Regulation of small GTPase activity by G1 cyclins

  • Pedraza González, Neus
  • Cemeli, Tània
  • Monserrat Monserrat, Maria Ventura
  • Garí Marsol, Eloi
  • Ferrezuelo, Francisco
Together with a cyclin-dependent kinase (CDK) partner G1 cyclins control cell cycle entry by phosphorylating a number of nuclear targets and releasing a transcriptional program at the end of G1 phase. Yeast G1 cyclins also operate on cytoplasmic targets involved in the polarization of the cytoskeleton and vesicle trafficking. These processes are mainly controlled by the small GTPase Cdc42, and G1 cyclins regulate the activity of this and other small GTPases through the modulation of their regulators and effectors. This regulation is key for different developmental outcomes in unicellular organisms. In mammalian cells cytoplasmic G1 cyclin D1 has been shown to promote the activity of Rac1 and Ral GTPases and to block RhoA. Regulation of these small GTPases by G1 cyclins may constitute a mechanism to coordinate proliferation with cell migration and morphogenesis, important processes not only during normal development and organogenesis but also for tumor formation and metastasis. Here we briefly review the evidence supporting a role of G1 cyclins and CDKs as regulators of the activity of small GTPases, emphasizing their functional relevance both in budding yeast and in mammalian cells., This work was funded by Spanish Ministry of Education and Science (BFU2013-42895) from the Spanish Ministry of Economy and Competitivity and Catalan Government (SGR-559). T. Cemeli and MV Monserrat were supported by predoctoral fellowships from Spanish Ministry of Education and Science (FPU) and from University of Lleida, respectively.
Repositori Obert UdL
Publicación Artículo científico (JournalArticle)

Cytoplasmic cyclin D1 regulates cell invasion and metastasis through the phosphorylation of paxillin

  • Pérez Fusté, Noel
  • Fernández Hernández, Rita
  • Cemeli, Tània
  • Mirantes Barbeito, Cristina
  • Pedraza González, Neus
  • Rafel i Borrell, Marta
  • Torres Rosell, Jordi
  • Colomina i Gabarrella, Neus
  • Ferrezuelo, Francisco
  • Dolcet Roca, Xavier
  • Garí Marsol, Eloi
Cyclin D1 (Ccnd1) together with its binding partner Cdk4 act as a transcriptional regulator to control cell proliferation and migration, and abnormal Ccnd1 . Cdk4 expression promotes tumour growth and metastasis. While different nuclear Ccnd1 . Cdk4 targets participating in cell proliferation and tissue development have been identified, little is known about how Ccnd1 . Cdk4 controls cell adherence and invasion. Here, we show that the focal adhesion component paxillin is a cytoplasmic substrate of Ccnd1 . Cdk4. This complex phosphorylates a fraction of paxillin specifically associated to the cell membrane, and promotes Rac1 activation, thereby triggering membrane ruffling and cell invasion in both normal fibroblasts and tumour cells. Our results demonstrate that localization of Ccnd1 . Cdk4 to the cytoplasm does not simply act to restrain cell proliferation, but constitutes a functionally relevant mechanism operating under normal and pathological conditions to control cell adhesion, migration and metastasis through activation of a Ccnd1 . Cdk4-paxillin-Rac1 axis., This work was funded by Spanish Ministry of Education and Science (BFU2013-42895) (CSD2007-00015), grants BFU2015–71308 and BFU2013–50245-EXP from the Spanish Ministry of Economy and Competitivity, Catalan Government (SGR-559), and Fondo de Investigaciones Sanitarias (PI10/00604). N.P. Fusté was supported by a predoctoral fellowship of University of Lleida-Fundació Alicia Cuello de Merigó, R. Fernández-Hernández (FPI) and T. Cemeli (FPU) were supported by predoctoral fellowships from Spanish Ministry of Education and Science, and C. Mirantes was supported by a predoctoral fellowship of Fondo de Investigaciones Sanitarias
Zaguán. Repositorio Digital de la Universidad de Zaragoza
Publicación Artículo científico (JournalArticle)

Cytoplasmic cyclin D1 regulates glioblastoma dissemination

  • Cemeli, Tània
  • Guasch-Vallés, Marta
  • Nàger, Mireia
  • Felip, Isidre
  • Cambray, Serafí
  • Santacana, Maria
  • Gatius, Sònia
  • Pedraza, Neus
  • Dolcet, Xavier
  • Ferrezuelo, Francisco
  • Schuhmacher, Alberto J
  • Herreros, Judit
  • Garí, Eloi
Glioblastoma (GBM) is a highly invasive brain neoplasia with an elevated recurrence rate after surgical resection. The cyclin D1 (Ccnd1)/Cdk4–retinoblastoma 1 (RB1) axis is frequently altered in GBM, leading to overproliferation by RB1 deletion or by Ccnd1‐Cdk4 overactivation. High levels of Ccnd1‐Cdk4 also promote GBM cell invasion by mechanisms that are not so well understood. The purpose of this work is to elucidate the in vivo role of cytoplasmic Ccnd1‐Cdk4 activity in the dissemination of GBM. We show that Ccnd1 activates the invasion of primary human GBM cells through cytoplasmic RB1‐independent mechanisms. By using GBM mouse models, we observed that evaded GBM cells showed cytoplasmic Ccnd1 colocalizing with regulators of cell invasion such as RalA and paxillin. Our genetic data strongly suggest that, in GBM cells, the Ccnd1‐Cdk4 complex is acting upstream of those regulators. Accordingly, expression of Ccnd1 induces focal adhesion kinase, RalA and Rac1 activities. Finally, in vivo experiments demonstrated increased GBM dissemination after expression of membrane‐targeted Ccnd1. We conclude that Ccnd1‐Cdk4 activity promotes GBM dissemination through cytoplasmic and RB1‐independent mechanisms. Therefore, inhibition of Ccnd1‐Cdk4 activity may be useful to hinder the dissemination of recurrent GBM. © 2019 Pathological Society of Great Britain and Ireland. Published by John Wiley & Sons, Ltd.
Recercat. Dipósit de la Recerca de Catalunya
Publicación Artículo científico (JournalArticle)

Characterization of cytoplasmic cyclin D1 as a marker of invasiveness in cancer

  • Pérez Fusté, Noel
  • Castelblanco Echavarría, Esmeralda
  • Felip Nogués, Isidre
  • Santacana Espasa, Maria
  • Fernández Hernández, Rita
  • Gatius Calderó, Sònia
  • Pedraza González, Neus
  • Pallares, Judit
  • Cemeli, Tània
  • Valls Marsal, Joan
  • Tarrés Escalona, Marc
  • Ferrezuelo, Francisco
  • Dolcet Roca, Xavier
  • Matias-Guiu, Xavier
  • Garí Marsol, Eloi
Cyclin D1 (Ccnd1) is a proto-oncogen amplified in many different cancers and nuclear accumulation of Ccnd1 is a characteristic of tumor cells. Ccnd1 activates the transcription of a large set of genes involved in cell cycle progress and proliferation. However, Ccnd1 also targets cytoplasmic proteins involved in the regulation of cell migration and invasion. In this work, we have analyzed by immunohistochemistry the localization of Ccnd1 in endometrial, breast, prostate and colon carcinomas with different types of invasion. The number of cells displaying membranous or cytoplasmic Ccnd1 was significantly higher in peripheral cells than in inner cells in both collective and pushing invasion patterns of endometrial carcinoma, and in collective invasion pattern of colon carcinoma. Also, the cytoplasmic localization of Ccnd1 was higher when tumors infiltrated as single cells, budding or small clusters of cells. To evaluate cytoplasmic function of cyclin D1, we have built a variant (Ccnd1-CAAX) that remains attached to the cell membrane therefore sequestering this cyclin in the cytoplasm. Tumor cells harboring Ccnd1-CAAX showed high levels of invasiveness and metastatic potential compared to those containing the wild type allele of Ccnd1. However, Ccnd1- CAAX expression did not alter proliferative rates of tumor cells. We hypothesize that the role of Ccnd1 in the cytoplasm is mainly associated with the invasive capability of tumor cells. Moreover, we propose that subcellular localization of Ccnd1 is an interesting guideline to measure cancer outcome., This work was funded by Spanish Ministry of Education and Science (BFU2010-20293/ BMC and BFU2013-42895-P), Catalan Government (SGR-559), and Fondo de Investigaciones Sanitarias (PI10/00604 and PI13/00263). X.M-G was supported by grants 2014SGR138, RD12/0036/0013, and Fundación Asociación Española contra el Cancer. Tumour samples were obtained with the support of Xarxa Catalana de Bancs de Tumors, and Plataforma de Biobancos ISCIII (PT13/0010/0014). NP. Fusté was supported by a contract from “Fundació Alicia Cuello de Merigó”. I. Felip and T. Cemeli were supported by a predoctoral fellowship from FPU-MINECO.
Recercat. Dipósit de la Recerca de Catalunya
Publicación Artículo científico (JournalArticle)

Polyphosphate is a key factor for cell survival after DNA damage in eukaryotic cells

  • Bru, Samuel
  • Samper Martín, Bàrbara
  • Quandt, Eva
  • Hernández Ortega, Sara
  • Martínez Laínez, Joan M
  • Garí Marsol, Eloi
  • Rafel i Borrell, Marta
  • Torres Torronteras, Javier
  • Martí, Ramón
  • Ribeiro, Mariana
  • Jiménez, Javier
  • Clotet, Josep
Cells require extra amounts of dNTPs to repair DNA after damage. Polyphosphate (polyP) is an evolutionary conserved linear polymer of up to several hundred inorganic phosphate (Pi) residues that is involved in many functions, including Pi storage. In the present article, we report on findings demonstrating that polyP functions as a source of Pi when required to sustain the dNTP increment essential for DNA repair after damage. We show that mutant yeast cells without polyP produce less dNTPs upon DNA damage and that their survival is compromised. In contrast, when polyP levels are ectopically increased, yeast cells become more resistant to DNA damage. More importantly, we show that when polyP is reduced in HEK293 mammalian cell line cells and in human dermal primary fibroblasts (HDFa), these cells become more sensitive to DNA damage, suggesting that the protective role of polyP against DNA damage is evolutionary conserved. In conclusion, we present polyP as a molecule involved in resistance to DNA damage and suggest that polyP may be a putative target for new approaches in cancer treatment or prevention., We would like to thank all the members of our group (E. Bállega, O. Mirallas, M. Ribeiro, A. Sánchez, B. Semper, and R. Carballar) for day-to-day talks, and Marta Pérez for technical assistance. The yeast ppn1Δ, ppn2Δ, ppx1Δ strain is a kind gift from A Mayer (Université de Lausanne). This work was supported by funding from the Spanish Government, with a MINECO grant (Ref: BFU 2013-44189-P) awarded to J. Clotet and a MICINN grant (Ref: BFU 2013-42895-P) awarded to E. Garí. J.M.M. was the recipient of a post-graduate Junior Faculty Fellowship from the UIC and l’Obra Social la Caixa.
Recercat. Dipósit de la Recerca de Catalunya
Publicación Artículo científico (JournalArticle)

Palbociclib has antitumour effects on Pten-deficient endometrial neoplasias, Inhibition of Cyclin D-CDK4/6 axis in PTEN-deficient neoplasias

  • Dosil Garcia, Maria Alba
  • Mirantes Barbeito, Cristina
  • Eritja Sánchez, Núria
  • Felip Nogués, Isidre
  • Navaridas Fernández de Bobadilla, Raúl
  • Gatius Calderó, Sònia
  • Santacana Espasa, Maria
  • Colás, Eva
  • Moiola, Cristian P.
  • Schoenenberger, Joan Antoni
  • Encinas Martín, Mario
  • Garí Marsol, Eloi
  • Matias-Guiu, Xavier
  • Dolcet Roca, Xavier
PTEN is one of the most frequently mutated genes in human cancers. The frequency of PTEN alterations is particularly high in endometrial carcinomas. Loss of PTEN leads to dysregulation of cell division, and promotes the accumulation of cell cycle complexes such as cyclin D1-CDK4/6, which is an important feature of the tumour phenotype. Cell cycle proteins have been presented as key targets in the treatment of the pathogenesis of cancer, and several CDK inhibitors have been developed as a strategy to generate new anticancer drugs. Palbociclib (PD-332991) specifically inhibits CDK4/6, and it has been approved for use in metastatic breast cancer in combination with letrazole. Here, we used a tamoxifen-inducible Pten knockout mouse model to assess the antitumour effects of cyclin D1 knockout and CDK4/6 inhibition by palbociclib on endometrial tumours. Interestingly, both cyclin D1 deficiency and palbociclib treatment triggered shrinkage of endometrial neoplasias. In addition, palbociclib treatment significantly increased the survival of Pten-deficient mice, and, as expected, had a general effect in reducing tumour cell proliferation. To further analyse the effects of palbociclib on endometrial carcinoma, we established subcutaneous tumours with human endometrial cancer cell lines and primary endometrial cancer xenografts, which allowed us to provide more translational and predictive data. To date, this is the first preclinical study evaluating the response to CDK4/6 inhibition in endometrial malignancies driven by PTEN deficiency, and it reveals an important role of cyclin D-CDK4/6 activity in their development., This work was supported by grants FIS PI13/00263, SAF2016-80157-R, PI13/01701, 2009SGR794,Grupos estables AECC (AECC2011), RETICS(RD12/0036/0013), Catalunya contra el cáncer, Programa de intensificación de la investigación, Instituto Carlos III, and BFU 2013-42895-P. MAD holds a predoctoral fellowship from Ministerio de Educación
Recercat. Dipósit de la Recerca de Catalunya
Publicación Artículo científico (JournalArticle)

Regulation of small GTPase activity by G1 cyclins

  • Pedraza González, Neus
  • Cemeli, Tània
  • Monserrat Monserrat, Maria Ventura
  • Garí Marsol, Eloi
  • Ferrezuelo, Francisco
Together with a cyclin-dependent kinase (CDK) partner G1 cyclins control cell cycle entry by phosphorylating a number of nuclear targets and releasing a transcriptional program at the end of G1 phase. Yeast G1 cyclins also operate on cytoplasmic targets involved in the polarization of the cytoskeleton and vesicle trafficking. These processes are mainly controlled by the small GTPase Cdc42, and G1 cyclins regulate the activity of this and other small GTPases through the modulation of their regulators and effectors. This regulation is key for different developmental outcomes in unicellular organisms. In mammalian cells cytoplasmic G1 cyclin D1 has been shown to promote the activity of Rac1 and Ral GTPases and to block RhoA. Regulation of these small GTPases by G1 cyclins may constitute a mechanism to coordinate proliferation with cell migration and morphogenesis, important processes not only during normal development and organogenesis but also for tumor formation and metastasis. Here we briefly review the evidence supporting a role of G1 cyclins and CDKs as regulators of the activity of small GTPases, emphasizing their functional relevance both in budding yeast and in mammalian cells., This work was funded by Spanish Ministry of Education and Science (BFU2013-42895) from the Spanish Ministry of Economy and Competitivity and Catalan Government (SGR-559). T. Cemeli and MV Monserrat were supported by predoctoral fellowships from Spanish Ministry of Education and Science (FPU) and from University of Lleida, respectively.
Recercat. Dipósit de la Recerca de Catalunya
Publicación Artículo científico (JournalArticle)

Cyclin D1 promotes tumor cell invasion and metastasis by cytoplasmic mechanisms

  • Pérez Fusté, Noel
  • Ferrezuelo, Francisco
  • Garí Marsol, Eloi
Amplification of cyclin D1 is a frequent alteration in many cancers of different type and origin. We recently described a novel regulatory axis involving cyclin D1 in the regulation of tumor invasion and metastasis. Membrane-associated cyclin D1-CDK4 complexes promote activation of the small GTPase RAC1 through phosphorylation of the regulatory protein paxillin., This work has been supported by research grants from Spanish Ministry of Education and Science (BFU2013-42895), Catalan Government (SGR-559), and Fundació Alicia Cuello de Merigó.
Recercat. Dipósit de la Recerca de Catalunya
Publicación Artículo científico (JournalArticle)

Cytoplasmic cyclin D1 regulates cell invasion and metastasis through the phosphorylation of paxillin

  • Pérez Fusté, Noel
  • Fernández Hernández, Rita
  • Cemeli, Tània
  • Mirantes Barbeito, Cristina
  • Pedraza González, Neus
  • Rafel i Borrell, Marta
  • Torres Rosell, Jordi
  • Colomina i Gabarrella, Neus
  • Ferrezuelo, Francisco
  • Dolcet Roca, Xavier
  • Garí Marsol, Eloi
Cyclin D1 (Ccnd1) together with its binding partner Cdk4 act as a transcriptional regulator to control cell proliferation and migration, and abnormal Ccnd1 . Cdk4 expression promotes tumour growth and metastasis. While different nuclear Ccnd1 . Cdk4 targets participating in cell proliferation and tissue development have been identified, little is known about how Ccnd1 . Cdk4 controls cell adherence and invasion. Here, we show that the focal adhesion component paxillin is a cytoplasmic substrate of Ccnd1 . Cdk4. This complex phosphorylates a fraction of paxillin specifically associated to the cell membrane, and promotes Rac1 activation, thereby triggering membrane ruffling and cell invasion in both normal fibroblasts and tumour cells. Our results demonstrate that localization of Ccnd1 . Cdk4 to the cytoplasm does not simply act to restrain cell proliferation, but constitutes a functionally relevant mechanism operating under normal and pathological conditions to control cell adhesion, migration and metastasis through activation of a Ccnd1 . Cdk4-paxillin-Rac1 axis., This work was funded by Spanish Ministry of Education and Science (BFU2013-42895) (CSD2007-00015), grants BFU2015–71308 and BFU2013–50245-EXP from the Spanish Ministry of Economy and Competitivity, Catalan Government (SGR-559), and Fondo de Investigaciones Sanitarias (PI10/00604). N.P. Fusté was supported by a predoctoral fellowship of University of Lleida-Fundació Alicia Cuello de Merigó, R. Fernández-Hernández (FPI) and T. Cemeli (FPU) were supported by predoctoral fellowships from Spanish Ministry of Education and Science, and C. Mirantes was supported by a predoctoral fellowship of Fondo de Investigaciones Sanitarias
Recercat. Dipósit de la Recerca de Catalunya
Publicación Artículo científico (JournalArticle)

Cytoplasmic Cyclin D1 regulates glioblastoma dissemination, Ccnd1-dependent GBM spread

  • Cemeli, Tània
  • Guasch Vallés, Marta
  • Nàger Grifo, Mireia
  • Felip Nogués, Isidre
  • Cambray Carner, Serafí
  • Santacana Espasa, Maria
  • Gatius Calderó, Sònia
  • Pedraza González, Neus
  • Dolcet Roca, Xavier
  • Ferrezuelo, Francisco
  • Schuhmacher, Alberto J.
  • Herreros Danés, Judit
  • Garí Marsol, Eloi
Glioblastoma (GBM) is a highly invasive brain neoplasia with an elevated recurrence rate after surgical resection. The CyclinD1 (Ccnd1)/Cdk4-RB1 axis is frequently altered in GBM, leading to over-proliferation by RB1 deletion or by Ccnd1/Cdk4 over-activation. By not so well understood mechanisms, high levels of Ccnd1-Cdk4 also promote GBM cell invasion. The purpose of this work is to elucidate the in vivo role of cytoplasmic Ccnd1-Cdk4 activity in the dissemination of GBM. We show that Ccnd1 activates invasion of primary human GBM cells through cytoplasmic RB1-independent mechanisms. By using GBM mouse models, we observed that evaded GBM cells showed cytoplasmic Ccnd1 co-localizing with regulators of cell invasion such as RalA and Paxillin. Our genetic data strongly suggest that, in GBM cells, the Ccnd1/Cdk4 complex is acting upstream of those regulators. Accordingly, expression of Ccnd1 induces FAK, RalA and Rac1 activities. Finally, in vivo experiments demonstrated increased GBM dissemination after expression of membrane-targeted Ccnd1. We conclude that Ccnd1-Cdk4 activity promotes GBM dissemination through cytoplasmic and RB1-independent mechanisms. Therefore, inhibition of Ccnd1-Cdk4 activity may be useful to hinder dissemination of recurrent GBM., We thank Sonia Rius, Marta Rafel, Laura Colas, Ana Velasco and Maria Ruiz (IRBLleida-Biobank) for technical assistance, and Maria Jesus Artiga and Patricia Gonzalez from Biobank and Histopathology Core Unit, CNIO for technical support. We especially thank Massimo Squatrito for providing the samples of the gliomagenesis model. This work was funded by the Spanish Ministry of Education and Science (BFU2013-42895-P; BFU2016-78826-P) and the Instituto de Salud Carlos III/FEDER (P13/01980), and supported by the Xarxa de Bancs de Tumors de Catalunya sponsored by Pla Director d'Oncologia de Catalunya (XBTC), IRBLleida Biobank (B.0000682) and PLATAFORMA BIOBANCOS PT17/0015/0027. T Cemeli (FPU13/06590) and I Felip (FPU14/02674) were supported by a predoctoral fellowship from Ministerio de Educacion, Cultura y Deportes and from Diputacio de Lleida. M Guasch and M Nager were supported by a predoctoral fellowship from UdL. AJ Schuhmacher was supported by a research contract from the Ramon y Cajal program (RYC-2015-17622) by the Spanish Ministry for the Economy, Industry and Competitiveness (MINECO).